Photo By Petty Officer 1st Class John Bellino | 210423-N-PC065-1021 NORFOLK, Va. (April 23, 2021) Hospitalman Marcus Wooten, assigned...... read more read more
Subscribe
NORFOLK, Va. – Sailors aboard the San Antonio-class amphibious transport dock ship USS Arlington (LPD 24) receive their second dose of the COVID-19 vaccine, April 23, 2021.
Arlington has the potential to be called upon at any point throughout this summer and fall to respond to a natural disaster at home or abroad.
“The USS Arlington is ideally suited to respond on short notice to a humanitarian crisis if needed,” said Capt. Chris “Chowdah” Hill, commanding officer of the Arlington. This vaccination will enable us to make contact with local communities in a disaster, and do so without increasing the threat of spreading more of the virus and further endangering the people we seek to help.”
The fight against COVID-19 is an all hands effort and that was on full display as Arlington’s health services department worked together with Sailors from Fleet Surgical Teams 2, 4 and 8, as well as staff from Naval Medicine Readiness Training Command, Portsmouth to complete the second series of the COVID-19 vaccine.
“Arlington Sailors finished strong with a take-rate of 98% for the second shot of the COVID-19 vaccine series,” said Lt. Caitlin Tallant, Arlington’s medical officer. “We are proud of our Sailors for helping to stop COVID and keep us ready for the high end fight."
Throughout the pandemic the Navy has incorporated policies that require strict compliance with CDC guidance regarding wearing masks, maintaining physical distance and other public health measures.
According to updates on the U.S. Navy website www.navy.mil, 69,711 Navy personnel are partially vaccinated and 145,939 are fully vaccinated as of April 21.
| Date Taken: | 04.23.2021 |
| Date Posted: | 04.24.2021 12:50 |
| Story ID: | 394677 |
| Location: | NORFOLK, US |
| Web Views: | 124 |
| Downloads: | 1 |
This work, Sailors do their part to sink COVID-19, by PO1 John Bellino, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
No keywords found.
LEAVE A COMMENT